The company previously announced unaudited preliminary fourth quarter net sales between $45.1 million to $46.6 million and full year 2024 preliminary unaudited net sales projected to range ...
Amgen (NASDAQ:AMGN) today announced that it will report its fourth quarter and full year 2024 financial results on Tuesday, February 4, 2025, after the close of the U.S. financial markets. The ...